Ahmed Bahi on Qatar’s Self-Infusion Program for Hemophilia Patients
Ahmed Bahi, Critical Care Pharmacist Specialist in Trauma Services at Hamad Medical Corporation, shared on LinkedIn:
”Exciting News from Qatar!
I’m thrilled to share the successful establishment of our self-infusion program for hemophilia patients, a collaborative effort between Qatar Foundation Health Group (QFHG) and the Hematology/Oncology team at Hamad Medical Corporation’s National Center for Cancer Care and Research (NCCCR).
This initiative included comprehensive didactic lectures and hands-on live stations, culminating in a knowledge assessment survey to ensure our patients feel empowered and informed.
A heartfelt thank you to everyone involved, especially:
– Dr. Osama Elhomsi
– Dr. Honar Cherif
– Dr. Liam Ferrnough
– Dr.Sheab Fared
– Dr.Amna Jameel
– Dr.Deena Mudawi
Your dedication and expertise made this program a reality, significantly improving the quality of life for hemophilia patients in our community.
Together, we are making strides toward better healthcare and patient empowerment!”
Stay updated with Hemostasis Today.
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies
-
May 26, 2026, 15:22Shazmah Shaikh: One Visual Guide to Understand All Major Anticoagulants
-
May 26, 2026, 14:39Chidinma Favour։ Welcome to Day 25 of My 31-Day Stroke Awareness Series
-
May 26, 2026, 14:35Novel Insights Into Congenital and Acquired Coagulopathies – ICHCC
-
May 26, 2026, 14:24Fernanda Orsi: The Growing Impact of Hematology Research in Latin America
-
May 26, 2026, 14:23Rense Buijvoets: What If Clots Could Be Treated Exactly Where They Form?